X0306 4 2020-11-09 0 0001805387 Cerevel Therapeutics Holdings, Inc. CERE 0001578965 Koppel Adam C/O BAIN CAPITAL LIFE SCIENCES INVESTORS 200 CLARENDON STREET BOSTON MA 02116 1 0 1 0 Common Stock 2020-11-09 4 P 0 332293 10.30 A 60632356 I See Footnote On November 9, 2020, BC Perception Holdings, LP ("BC Perception") purchased 332,293 shares of the Issuer's Common Stock at a price of $10.30 per share. Adam Koppel is a Managing Director of Bain Capital Life Sciences Investors, LLC, which is the ultimate general partner of Bain Capital Life Sciences Fund, LP. As a result, Dr. Koppel may be deemed to share voting and dispositive power with respect to the securities held by BC Perception. Dr. Koppel disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. /s/ Adam Koppel 2020-11-12